News
265 - 268 of 325 news items
Councillors from the Royal Borough of Kensington and Chelsea tore into NHS England’s proposals to withdraw vital heart and lung services from Royal Brompton Hospital on Tuesday evening (11 July), and demanded they produce evidence that so-called ‘co-located’ services produce better outcomes for patients.
Orkambi, a combination drug for cystic fibrosis, has been found to improve the lung function of children suffering from the disease.
Royal Brompton & Harefield NHS Foundation Trust has been awarded special funding from the Cystic Fibrosis Trust to scale up its clinical trials for the disease, which help to pioneer new treatments for patients across the country.
Campaigners fighting the closure of the Trust’s congenital heart disease (CHD) services today launch a new film to encourage people to respond to NHS England’s public consultation.